Arthrosis treatment with stem cells in Turkey: what it is and how it works
Arthrosis treatment with stem cells is an orthopaedic procedure designed to manage chronic joint degradation, calm intra-articular inflammation, and alleviate persistent joint pain. Osteoarthritis (arthrosis) involves the progressive loss of articular cartilage, resulting in stiff, painful joints and restricted mobility. Rather than implanting artificial prosthetics, this biological therapy collects a patient’s own adult cells—usually from bone marrow or adipose fat tissue—concentrates them in a sterile laboratory setting, and injects them directly into the joint space. International clinics offer it as part of regenerative treatments in Turkey for patients seeking joint-preserving care.
The therapy aims to manage symptoms and protect surviving cartilage; it does not constitute an instant cure or regrow an entirely new joint. It is most effective when joint alignment is preserved and moderate cartilage remains. This guide outlines how autologous cells work inside the joint, what clinical evidence confirms, approximate costs compared with the UK, US, and Germany, expected recovery phases, and how to verify clinic credentials.
How does arthrosis treatment with stem cells work inside the joint?
Understanding what is arthrosis treatment with stem cells starts with the biological activity of mesenchymal stem cells (MSCs) and progenitor cells. In an arthritic joint, catabolic inflammation and destructive enzymes gradually break down cartilage. Injected stem cells do not simply transform into new cartilage tissue. Instead, their therapeutic benefit relies on paracrine signalling—the release of anti-inflammatory cytokines, growth factors, and extracellular vesicles directly into the synovial fluid.
These concentrated cells alter the joint environment by suppressing inflammation, slowing matrix degradation, and supporting native chondrocytes. This biological calming effect reduces synovial swelling and relieves pressure on sensitive joint nerves. Protocols typically use bone marrow aspirate concentrate (BMAC) from the pelvis or stromal vascular fraction (SVF) derived from microfragmented adipose tissue.
Does arthrosis treatment with stem cells actually work?
Patients considering cellular therapy ask: does arthrosis treatment with stem cells work? Clinical research and orthopaedic registries show that autologous cell injections can deliver meaningful pain reduction and functional improvement for mild-to-moderate osteoarthritis (grades 2 and 3). Studies indicate that a targeted injection can improve joint mobility and reduce dependency on painkillers for 12 to 24 months.
However, professional societies such as the International Cartilage Regeneration & Joint Preservation Society (ICRS) stress that cellular injections cannot reconstruct joint surfaces when cartilage has worn down to bare bone (grade 4 arthrosis). Reputable orthopaedic surgeons will not claim that stem cells replace joint surgery in end-stage disease. The realistic goal is symptom relief, improved everyday function, and postponing major surgery.
Arthrosis treatment with stem cells cost in Turkey, the UK, US, and Germany
The arthrosis treatment with stem cells cost depends on the tissue source (bone marrow or adipose fat), whether one or both joints are treated, and the processing technology used. The figures below show typical price ranges across major destinations. These are approximate estimates rather than hospital-specific quotes, and each hospital confirms pricing after reviewing your medical scans.
| Country | Approximate cost range |
|---|---|
| Turkey | €1,800 – €4,500 |
| United Kingdom | €4,500 – €9,500 |
| United States | €5,000 – €14,000 |
| Germany | €4,000 – €9,000 |
Key factors influencing the overall arthrosis treatment with stem cells price include whether both knees are treated, the anaesthesia method, and theatre disposables. International packages in Turkey generally include the orthopaedic consultation, MRI review, procedure fees, local anaesthesia with sedation, follow-up checks, medications, and airport transfers.
Stem cell therapy, PRP, or joint replacement for arthrosis?
Choosing an orthopaedic approach requires comparing cellular injections with established alternatives. Platelet-rich plasma (PRP) introduces concentrated growth factors from blood, whereas stem cells provide nucleated cells with prolonged paracrine activity. For severe end-stage damage, joint replacement remains the standard. For an overview of cellular protocols, see our guide to treatment with stem cells.
| Treatment approach | Best suited to | Typical limits |
|---|---|---|
| Stem cell therapy (BMAC / SVF) | Moderate osteoarthritis (grade 2–3) with persistent pain | Does not regrow full joint cartilage in end-stage wear |
| Platelet-rich plasma (PRP) | Mild to early-moderate joint wear and soft-tissue inflammation | Shorter symptom relief; often requires repeated injection courses |
| Total joint replacement (arthroplasty) | Severe, end-stage osteoarthritis (grade 4) with bone-on-bone contact | Major surgery with extended rehabilitation and prosthetic lifespan limits |
Each method suits a particular stage. PRP offers short-term anti-inflammatory relief in early wear, while stem cell therapy provides deeper biological support for moderate disease. When mechanical breakdown is complete, surgical reconstruction is necessary.
Which joints and arthrosis grades can be treated?
Cellular therapies are most frequently used in weight-bearing joints exposed to daily mechanical stress. The knee is by far the most treated joint, accounting for most published research. Patients with cartilage loss under the kneecap or in the main joint compartments frequently explore this option. Hip arthrosis is also treated, requiring ultrasound or fluoroscopic guidance to reach the deep joint capsule. Other treated sites include shoulders, ankles, and base-of-thumb joints.
Radiographic severity determines suitability. Grade 1 wear is managed with exercise and lifestyle measures. Grades 2 and 3—characterized by joint space narrowing and preserved alignment—represent the primary window for stem cell therapy. In grade 4 arthrosis, where cartilage has completely eroded and bone rubs against bone, injections provide little lasting benefit.
Who is a suitable candidate for cellular joint therapy?
A good candidate is an adult with documented mild-to-moderate arthrosis who has not achieved adequate relief from physiotherapy, lifestyle changes, or joint lubrication injections. Candidates should have preserved mechanical joint alignment, as severe angular deformities place excessive load on treated surfaces. Realistic expectations about pain reduction and function are vital.
Contraindications include active joint or systemic infections, haematological malignancies, ongoing cancer treatment, severe bleeding disorders, and uncontrolled diabetes. Severe obesity also reduces treatment efficacy by placing excessive mechanical stress on the healing joint. Surgeons review imaging and medical history before confirming eligibility.
The treatment procedure step by step: harvesting to injection
The procedure is carried out as a day case under local anaesthesia with light sedation, lasting between 90 minutes and two hours. To understand clinical coordination, see our guide on treatment with stem cells.
1. Tissue harvesting
The surgeon harvests tissue from either the pelvic bone or abdominal fat. For bone marrow (BMAC), an aspiration needle enters the iliac crest under local anaesthesia to collect marrow fluid. For adipose tissue (SVF), a gentle mini-liposuction collects a small volume of abdominal fat.
2. Laboratory processing
The harvested tissue is immediately processed in a sterile closed-system centrifuge inside the operating suite. This separates red cells or oil, isolating concentrated progenitor cells and protective cytokines without air exposure.
3. Image-guided injection
Using real-time ultrasound or fluoroscopy, the surgeon guides the needle into the exact intra-articular space. Image guidance ensures the concentrated cells are placed directly within the joint capsule rather than surrounding tissues.
Trip timeline and arthrosis treatment with stem cells recovery
Travelling for arthrosis treatment with stem cells Turkey typically requires a stay of three to four nights. Day one involves hospital registration, blood work, and an orthopaedic consultation with MRI evaluation. Day two is procedure day. Day three includes a post-treatment check and mobility review before flying home on day four.
Understanding arthrosis treatment with stem cells recovery ensures realistic planning. Recovery is straightforward because there is no bone cutting. Mild swelling and stiffness are normal for the first 48 to 72 hours. Crutches are used for two to three days to limit joint impact. Desk work can resume within three to five days. Gentle walking and stationary cycling begin after two weeks, while heavy running and high-impact sports should be paused for six weeks.
Risks, safety standards, and regulatory considerations
Because autologous cells come from your own body, there is no risk of graft rejection or allergic reaction. Common mild effects include temporary soreness, joint swelling, and bruising at the harvest site. Serious complications such as joint infection occur in fewer than one in a thousand cases when strict sterile operating conditions are maintained.
Safety depends on accredited laboratory standards. Health authorities, including the UK Medicines and Healthcare products Regulatory Agency (MHRA) and US FDA, caution against unregulated clinics using unapproved cell preparations. In Turkey, cellular therapies are strictly regulated by the Ministry of Health, requiring accredited hospital facilities and closed-system processing. Choosing an accredited hospital under specialist care ensures high standards of safety.
Choosing a clinic in Turkey and questions to ask your doctor
Ensure your procedure is performed by an orthopaedic surgeon registered with national specialty boards, within an accredited hospital using certified closed-loop cell preparation systems. Read how it works to understand pre-travel medical reviews, and request an evaluation via our free quote page. Our advisors explain how it works and assist with doctor communications.
When reviewing arthrosis treatment with stem cells before and after accounts, remember that external photographs do not reflect cartilage status; focus on documented pain scores (such as WOMAC) and follow-up MRI reports. Red flags include promises of complete cartilage regrowth, guarantees that surgery is avoided forever, and quotes issued without reviewing your MRI.
Essential questions to ask your medical team:
- Which cell source (bone marrow or adipose tissue) suits my joint condition, and why?
- Will the injection be delivered under ultrasound or fluoroscopic guidance?
- What closed-system technology is used to prepare the cell concentrate?
- What realistic improvement in pain and mobility can I expect for my joint grade?
- What physical therapy routine should I follow during the initial weeks?
- What follow-up support is provided after I return home?
Conditions treated with Arthrosis Treatment with Stem Cells
Hospitals with Regenerative Medicine in Turkey
Frequently asked questions
Arthrosis treatment with stem cells is an orthopaedic procedure that uses concentrated autologous cells from your own bone marrow or adipose tissue. Injected directly into an arthritic joint under ultrasound or fluoroscopic guidance, these cells release anti-inflammatory cytokines and growth factors to reduce pain, ease stiffness, and protect remaining cartilage.
Yes, for mild to moderate osteoarthritis (grades 2 and 3). Clinical studies show that autologous cell injections can significantly reduce joint pain and improve physical function for 12 to 24 months. However, it cannot regrow cartilage in severe bone-on-bone disease (grade 4), so realistic expectations and proper candidate selection are essential.
In Turkey, arthrosis treatment with stem cells generally ranges between €1,800 and €4,500 per joint. This compares with €4,500 to €9,500 in the UK and up to €14,000 in the US. The price depends on whether bone marrow or adipose tissue is used and whether both joints are treated.
Before treatment, patients typically experience chronic joint ache, stiffness, and reduced walking tolerance. After treatment, swelling subsides within two weeks, with progressive pain relief and improved joint mobility developing over two to three months. Follow-up imaging often shows reduced joint effusion and stabilized cartilage margins rather than total cartilage regeneration.
Recovery is relatively swift because the treatment requires no surgical incisions into the joint. Most patients walk gently with crutches for two to three days, return to light desk work within five days, and resume low-impact exercise such as swimming or cycling after two to three weeks. High-impact sports are paused for six weeks.
The procedure involves minimal discomfort. Local anaesthesia and mild sedation are administered during bone marrow aspiration or mini-liposuction harvesting, as well as during the joint injection. Afterwards, patients often experience temporary soreness, fullness, or stiffness in the joint for 48 to 72 hours, which is easily managed with standard oral painkillers.
Clinical data indicate that symptom relief and functional gains typically last between one and two years, depending on the severity of joint wear, body weight, and physical activity levels. While the injected cells do not halt arthrosis permanently, the treatment can effectively delay the need for joint replacement surgery.
Because autologous cells are harvested from your own body, there is no risk of tissue rejection or allergic reaction. When performed under sterile operating conditions with closed-system processing and imaging guidance, procedural risks are low. Minor temporary swelling is common, while serious complications such as infection occur in fewer than 0.1% of procedures.
Stem cell therapy suits patients with moderate arthrosis (grades 2 to 3) who want to reduce pain and postpone invasive surgery while preserving their natural joint. Total joint replacement is reserved for end-stage arthrosis (grade 4), where cartilage is completely gone, severe bone deformities exist, and biological therapies can no longer restore joint function.
Most patients stay in Turkey for three to four nights. This allows sufficient time for pre-procedure blood tests, orthopaedic consultation, diagnostic imaging review, the injection procedure, and a follow-up assessment before flying home safely. Travelling home is usually comfortable with standard airport assistance.